Letter to Editor
Sir, I am quite delighted to respond to observations on our article. This study as with every other study has a primary aim. The aim of the study we published in CHRISMED Journal of Health Research, [1] was to determine the baseline seroprevalence of herpes simplex virus 2 (HSV-2), chlamydia, and syphilis among antenatal patients in our locality, and it was not our aim to determine the association between human immunodeficiency virus (HIV) and other sexually transmitted diseases. It should however be noted that the findings from that report should be treated as point prevalence in a longitudinal survey. The association between HIV and HSV-2 among pregnant women in our locality using same individuals has been studied by Osazuwa et al. [2] and published in a separate publication. [2] In the study, the seroprevalence of HSV-2 and HIV was 192 (60.8%) and 24 (7.6%), respectively. The prevalence of HIV was higher among HSV-2 seropositive individuals than in seronegative individuals. HSV-2 seropositivity was significantly associated with a higher odd of outcome of HIV infection (odd ratio = 3.497, relative risk [RR] = 3.2, P = 0.018) using precise ratio of proportion estimates from prism report to determine RR of HIV acquisition. Please check the article [2] for more detailed description of outcome of the research. The association between HIV and other STIs (chlamydia and syphilis) among pregnant women in our locality is still under analysis; this will be reported at a later date.
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